Palvella Therapeutics, Inc. (PVLA)

Palvella Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	825	135	-	-
Enterprise Value	775	215	-	-
Last Close Price	75.17	12.00	-	-
PB Ratio	17.40	2.15	-	-
P/TBV Ratio	17.40	2.15	-	-
Debt / Equity Ratio	0.30	0.19	-2.08	-1.40
Quick Ratio	7.53	7.14	3.11	2.78
Current Ratio	7.67	7.33	3.20	2.86
Return on Equity (ROE)	-151.15%	-59.37%	-	-
Return on Assets (ROA)	-37.25%	-18.39%	-61.63%	-
Return on Capital (ROIC)	-46.16%	-22.38%	-110.58%	-
Earnings Yield	-3.37%	-12.95%	-	-
Buyback Yield / Dilution	-19.89%	-24.08%	68.63%	-

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q